Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Biological Data. | Cancers (Basel) | 2023 | 36765742 | PubTator, text mining | PubMed |
| Transcription factor SOX15 regulates stem cell pluripotency and promotes neural fate during differentiation by activating the neurogenic gene Hes5. | J Biol Chem | 2023 | 36764520 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine. | Front Immunol | 2023 | 36761744 | PubTator, text mining | PubMed |
| EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 36760869 | PubTator, text mining | PubMed |
| PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma. | Sci Rep | 2023 | 36739300 | PubTator, text mining | PubMed |
| Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma. | J Clin Invest | 2023 | 36719749 | PubTator, text mining | PubMed |
| Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma. | BMC Cancer | 2023 | 36717792 | PubTator, text mining | PubMed |
| ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation. | Sci Rep | 2023 | 36709331 | PubTator, text mining | PubMed |
| Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis. | Cancer Med | 2023 | 36708070 | PubTator, text mining | PubMed |
| Heparanase-1: From Cancer Biology to a Future Antiviral Target. | Viruses | 2023 | 36680276 | PubTator, text mining | PubMed |
| An Adenovirus-Based Recombinant Herpes Simplex Virus 2 (HSV-2) Therapeutic Vaccine Is Highly Protective against Acute and Recurrent HSV-2 Disease in a Guinea Pig Model. | Viruses | 2023 | 36680259 | PubTator, text mining | PubMed |
| Immunologic Signatures across Molecular Subtypes and Potential Biomarkers for Sub-Stratification in Endometrial Cancer. | Int J Mol Sci | 2023 | 36675305 | PubTator, text mining | PubMed |
| A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients. | Int J Mol Sci | 2023 | 36675190 | PubTator, text mining | PubMed |
| Mining TCGA Database for Genes with Prognostic Value in Breast Cancer. | Int J Mol Sci | 2023 | 36675137 | PubTator, text mining | PubMed |
| The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer. | Int J Mol Sci | 2023 | 36675020 | PubTator, text mining | PubMed |
| Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors? | Int J Mol Sci | 2023 | 36674491 | PubTator, text mining | PubMed |
| DNA and RNA Alterations Associated with Colorectal Peritoneal Metastases: A Systematic Review. | Cancers (Basel) | 2023 | 36672497 | PubTator, text mining | PubMed |
| Comparison of histological and molecular features of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma. | Virchows Arch | 2023 | 36656392 | PubTator, text mining | PubMed |
| Antiviral Potential of Melissa officinalis L.: A Literature Review. | Nutr Metab Insights | 2023 | 36655201 | PubTator, text mining | PubMed |
| LIGHT Amplification by NF-κB Contributes to TLR3 Signaling Pathway-Induced Acute Hepatitis. | Mediators Inflamm | 2023 | 36654880 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=37